Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy

Keyphrases

• Induction Therapy 100%
• Hepatitis 100%
• Renal Transplant Recipients 100%
• Alemtuzumab 100%
• Latent Infection 33%
• Latent Tuberculosis Infection 33%
• Mycobacterium Tuberculosis (M. tb) 33%
• Mycobacterium Tuberculosis Infection 33%
• Chemoprophylaxis 33%
• Active Tuberculosis 33%
• Graft Function 33%
• Opportunistic Infections 33%
• Transplant Management 33%
• Renal Transplant 33%
• Solid Organ Transplantation 33%
• Disseminated Infection 33%
• Donor-derived 33%
• Deceased Donor Kidney Transplantation 33%
• Febrile Syndrome 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alemtuzumab 100%
• Infection 66%
• Latent Tuberculosis 33%
• Syndrome 33%
• Chemoprophylaxis 33%
• Opportunistic Infection 33%
• Diseases 33%
• Side Effect 33%